Horizon Kinetics Asset Management’s Beam Therapeutics BEAM Stock Holding History

Horizon Kinetics Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$209K	Sell	8,791 -403	-4%	-$11.2K	﹤0.01%	297
2025 Q4	$255K	Sell	9,194 -403	-4%	-$10.3K	﹤0.01%	270
2025 Q3	$233K	Buy	+9,597	New	+$191K	﹤0.01%	287
2025 Q1	–	Sell	-9,597	Closed	-$238K	–	351
2024 Q4	$238K	Buy	9,597 +403	+4%	+$10.3K	﹤0.01%	293
2024 Q3	$225K	Sell	9,194 -403	-4%	-$10.4K	﹤0.01%	300
2024 Q2	$225K	Hold	9,597	–	–	﹤0.01%	277
2024 Q1	$317K	Hold	9,597	–	–	0.01%	249
2023 Q4	$261K	Sell	9,597 -403	-4%	-$10K	0.01%	263
2023 Q3	$241K	Hold	10,000	–	–	﹤0.01%	265
2023 Q2	$319K	Hold	10,000	–	–	0.01%	258
2023 Q1	$306K	Buy	+10,000	New	+$395K	0.01%	256

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Horizon Kinetics Asset Management's BEAM Position: Q1 2026 in Review

Horizon Kinetics Asset Management reduced its Beam Therapeutics (BEAM) stake by 4.4% in Q1 2026, selling an estimated $11.2K and leaving 8,791 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Horizon Kinetics Asset Management first reported a position in BEAM in Q1 2023 and has held it in 11 quarters since. The position peaked at $319K in Q2 2023. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Horizon Kinetics Asset Management held 8,791 shares of Beam Therapeutics worth $209K as of Q1 2026.
Horizon Kinetics Asset Management sold 403 Beam Therapeutics shares in Q1 2026, an estimated $11.2K.
Beam Therapeutics made up ﹤0.01% of Horizon Kinetics Asset Management's portfolio in Q1 2026, its #297 holding.
Horizon Kinetics Asset Management first reported a position in Beam Therapeutics in Q1 2023 and has held it in 11 quarters since.
Horizon Kinetics Asset Management's Beam Therapeutics position peaked at $319K in Q2 2023.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2026, filed 15 May 2026.